AU4303600A - Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate - Google Patents

Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate

Info

Publication number
AU4303600A
AU4303600A AU43036/00A AU4303600A AU4303600A AU 4303600 A AU4303600 A AU 4303600A AU 43036/00 A AU43036/00 A AU 43036/00A AU 4303600 A AU4303600 A AU 4303600A AU 4303600 A AU4303600 A AU 4303600A
Authority
AU
Australia
Prior art keywords
acetylsalcylic
acid
pharmaceutical composition
unit form
form containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43036/00A
Inventor
Bernard Abramovici
Jean Lheritier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU4303600A publication Critical patent/AU4303600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
AU43036/00A 1999-04-30 2000-04-25 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate Abandoned AU4303600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905497 1999-04-30
FR9905497A FR2792836B3 (en) 1999-04-30 1999-04-30 PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE
PCT/FR2000/001086 WO2000066130A1 (en) 1999-04-30 2000-04-25 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate

Publications (1)

Publication Number Publication Date
AU4303600A true AU4303600A (en) 2000-11-17

Family

ID=9545071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43036/00A Abandoned AU4303600A (en) 1999-04-30 2000-04-25 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate

Country Status (24)

Country Link
EP (1) EP1178809A1 (en)
JP (1) JP2002543137A (en)
KR (1) KR20020005735A (en)
CN (1) CN1359294A (en)
AR (1) AR023789A1 (en)
AU (1) AU4303600A (en)
BR (1) BR0010194A (en)
CA (1) CA2371231A1 (en)
CZ (1) CZ20013887A3 (en)
EA (1) EA200100959A1 (en)
EE (1) EE200100559A (en)
FR (1) FR2792836B3 (en)
HK (1) HK1041823A1 (en)
HU (1) HUP0202329A2 (en)
IL (1) IL145648A0 (en)
IS (1) IS6084A (en)
MX (1) MXPA01011071A (en)
NO (1) NO20015295L (en)
NZ (1) NZ514248A (en)
PL (1) PL351923A1 (en)
SK (1) SK15542001A3 (en)
TR (1) TR200103039T2 (en)
UY (1) UY26131A1 (en)
WO (1) WO2000066130A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100692934B1 (en) 2000-12-25 2007-03-12 상꾜 가부시키가이샤 Medicinal compositions containing aspirin
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
JP4917255B2 (en) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 Oral composition containing salicylic acids
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
CA2611741A1 (en) * 2005-06-13 2006-12-28 Elan Pharma International, Limited Nanoparticulate clopidogrel and aspirin combination formulations
KR20070009851A (en) * 2005-07-14 2007-01-19 씨제이 주식회사 Pharmaceutical compositions containing clopidogrel bisulfate
CN101253179B (en) * 2005-09-21 2010-12-29 株式会社钟根堂 Novel resinate complex of S-clopidogrel and production method thereof
KR20070044323A (en) * 2005-10-24 2007-04-27 에스케이케미칼주식회사 Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate
US20100145053A1 (en) * 2006-04-05 2010-06-10 Cadila Healthcare Limited Modified release clopidogrel formulation
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
WO2009104932A2 (en) * 2008-02-22 2009-08-27 한올제약주식회사 Composite preparation
CN101695496A (en) * 2009-10-15 2010-04-21 苏春华 Medicinal composition containing triflusal and clopidogrel
JP2013032289A (en) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd Wax stable formulation
RU2484820C2 (en) * 2011-02-24 2013-06-20 Общество с ограниченной ответственностью "Озон" Combined medicine as thrombocyte aggregation inhibitor
KR101675501B1 (en) 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 Combination of Clopidogrel and Aspirin
CN102406938A (en) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 Medicine composition for resisting thrombosis
JP6004524B2 (en) * 2012-07-11 2016-10-12 大原薬品工業株式会社 Method for producing clopidogrel sulfate-containing tablets
JP5905165B2 (en) * 2013-08-02 2016-04-20 サノフイ Pharmaceutical tablets containing acetylsalicylic acid and clopidogrel
CN104434932B (en) * 2014-12-18 2017-05-24 成都苑东生物制药股份有限公司 Pharmaceutical composition of clopidogrel hydrogen sulfate and acetylsalicylic acid tablet and preparation method thereof
WO2017037741A1 (en) * 2015-09-02 2017-03-09 Sun Pharmaceutical Industries Ltd Compact solid dosage form of aspirin and clopidogrel
CN115737578A (en) * 2022-11-23 2023-03-07 石家庄四药有限公司 Clopidogrel hydrogen sulfate and aspirin compound tablet and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (en) 1987-02-17 1992-01-24 Sanofi Sa ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2744918B1 (en) 1996-02-19 1998-05-07 Sanofi Sa NEW COMBINATIONS OF ACTIVE INGREDIENTS CONTAINING THIENO (3,2-C) PYRIDINE DERIVATIVE AND AN ANTITHROMBOTIC
FR2779726B1 (en) 1998-06-15 2001-05-18 Sanofi Sa POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE

Also Published As

Publication number Publication date
FR2792836A1 (en) 2000-11-03
JP2002543137A (en) 2002-12-17
NO20015295L (en) 2001-12-21
AR023789A1 (en) 2002-09-04
WO2000066130A1 (en) 2000-11-09
EP1178809A1 (en) 2002-02-13
NZ514248A (en) 2003-06-30
BR0010194A (en) 2002-02-13
HUP0202329A2 (en) 2002-10-28
IS6084A (en) 2001-09-25
TR200103039T2 (en) 2002-01-21
MXPA01011071A (en) 2002-07-22
EE200100559A (en) 2003-02-17
IL145648A0 (en) 2002-06-30
HK1041823A1 (en) 2002-07-26
PL351923A1 (en) 2003-06-30
SK15542001A3 (en) 2002-02-05
CA2371231A1 (en) 2000-11-09
NO20015295D0 (en) 2001-10-29
EA200100959A1 (en) 2002-06-27
KR20020005735A (en) 2002-01-17
CN1359294A (en) 2002-07-17
UY26131A1 (en) 2000-12-29
CZ20013887A3 (en) 2002-02-13
FR2792836B3 (en) 2001-07-27

Similar Documents

Publication Publication Date Title
AU4303600A (en) Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0202338A3 (en) Pharmaceutical composition containing fenofibrate and preparation method
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0203895A3 (en) Substituted azaindoles and pharmaceutical compositions containing them and their use
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0200548A2 (en) Pharmaceutical compositions and their use
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
HUP0001471A3 (en) Pharmaceutical compositions containing amoxicilline and clavulanic acid potassium salt
HUP0203575A3 (en) Pharmaceutical compositions containing th2 differentiation inhibitors and their use
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
HUP0202788A3 (en) Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
AU6038601A (en) Amino acid derivatives and their use as medicines
HUP0303204A3 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing them
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0300557A3 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
AU5587800A (en) S-(+)-desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions